The N291S LHCGR variant was revealed to alter glycosylation status and to increase receptor sensitivity, but no associations with breast cancer were found, while N312S was more frequent in women with breast cancer than in controls, without significant functional consequence12. Here, LHCGR is linked to breast carcinoma.